Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.bmcl.2014.02.006
DC Field | Value | |
---|---|---|
dc.title | Functionalized acridin-9-yl phenylamines protected neuronal HT22 cells from glutamate-induced cell death by reducing intracellular levels of free radical species | |
dc.contributor.author | Nguyen, T. | |
dc.contributor.author | Yang, T. | |
dc.contributor.author | Go, M.-L. | |
dc.date.accessioned | 2014-10-29T01:53:10Z | |
dc.date.available | 2014-10-29T01:53:10Z | |
dc.date.issued | 2014-04-01 | |
dc.identifier.citation | Nguyen, T., Yang, T., Go, M.-L. (2014-04-01). Functionalized acridin-9-yl phenylamines protected neuronal HT22 cells from glutamate-induced cell death by reducing intracellular levels of free radical species. Bioorganic and Medicinal Chemistry Letters 24 (7) : 1830-1838. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bmcl.2014.02.006 | |
dc.identifier.issn | 14643405 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/105972 | |
dc.description.abstract | The in vitro neuronal cell death model based on the HT22 mouse hippocampal cell model is a convenient means of identifying compounds that protect against oxidative glutamate toxicity which plays a role in the development of certain neurodegenerative diseases. Functionalized acridin-9-yl-phenylamines were found to protect HT22 cells from glutamate challenge at submicromolar concentrations. The Aryl1-NH-Aryl2 scaffold that is embedded in these compounds was the minimal pharmacophore for activity. Mechanistically, protection against the endogenous oxidative stress generated by glutamate did not involve up-regulation of glutathione levels but attenuation of the late stage increases in mitochondrial ROS and intracellular calcium levels. The NH residue in the pharmacophore played a crucial role in this regard as seen from the loss of neuroprotection when it was structurally modified or replaced. That the same NH was essential for radical scavenging in cell-free and cell-based systems pointed to an antioxidant basis for the neuroprotective activities of these compounds. © 2014 Elsevier Ltd. All rights reserved. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.bmcl.2014.02.006 | |
dc.source | Scopus | |
dc.subject | Acridin-9-yl phenylamines | |
dc.subject | Glutamate challenge | |
dc.subject | Mouse hippocampal cells HT22 | |
dc.subject | Neuroprotection | |
dc.subject | Oxytosis | |
dc.subject | Radical quenching | |
dc.type | Article | |
dc.contributor.department | PHARMACY | |
dc.description.doi | 10.1016/j.bmcl.2014.02.006 | |
dc.description.sourcetitle | Bioorganic and Medicinal Chemistry Letters | |
dc.description.volume | 24 | |
dc.description.issue | 7 | |
dc.description.page | 1830-1838 | |
dc.description.coden | BMCLE | |
dc.identifier.isiut | 000333567600043 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.